Chymase Inhibition Attenuates Monocrotaline-Induced Sinusoidal Obstruction Syndrome in Hamsters

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|21|2723-2729

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.21, 2013-01, pp. : 2723-2729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor

By Han Dan-Dan   Wang Yun   Zhang Xin-Hua   Liu Jin-Rong   Wang Huai-Liang  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 4, 2012-04 ,pp. : 445-454

NRC Research Press

Access to resources Recommend Favorite

Hemin Treatment Abrogates Monocrotaline-Induced Pulmonary Hypertension

By  

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 572-576

Bentham Science Publishers

Access to resources Recommend Favorite

Doxycycline: First report of sinusoidal obstruction syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem

By Takahashi T.   Kanda T.   Imai S.   Suzuki T.   Kobayashi I.   Murata K.  

European Journal of Pharmacology, Vol. 295, Iss. 2, 1996-01 ,pp. : 229-234

Elsevier

Access to resources Recommend Favorite

Teicoplanin/voriconazole: Sinusoidal obstruction syndrome in a stem cell transplant recipient, treated with defibrotide: case report

By  

Reactions Weekly, Vol. 1, Iss. 1243, 2009-01 ,pp. : 42-42

Adis International

Access to resources Recommend Favorite